A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. An ...
The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The ...
Weight loss injections could help to reduce asthma symptoms in obese people, according to researchers at the University of Aberdeen. The study by an international team of scientists found as well as ...
Long-acting muscarinic antagonists (LAMAs), as add-on therapy to inhaled corticosteroids, improved peak forced expiratory volume in 1 second (FEV1) and reduced exacerbations in children younger than ...
A digital, noninvasive home‑monitoring system — integrating home spirometry, smartwatch data, and medical feedback — showed promise for managing pediatric asthma. Nocturnal heart rate monitoring was ...
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published today in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback